Select Medical Holdings (NYSE: SEM) reported Q3 EPS of $0.14, $0.02 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.

Business Outlook

Select Medical is updating its business outlook following the reporting of its third quarter results. Select Medical now expects for the full year of 2017 consolidated net operating revenues to be in the range of $4.4 billion to $4.5 billion and Adjusted EBITDA for the full year of 2017 to be in the range of $530.0 million to $550.0 million. Select Medical now expects fully diluted income per common share for the full year 2017 to be in the range of $0.72 to $0.82 and fully diluted adjusted income per common share for the full year 2017 to be in the range of $0.81 to $0.91. Fully diluted adjusted income per common share excludes the non-operating loss and loss on early retirement of debt and their related tax effects.

GUIDANCE:

Select Medical Holdings sees FY2017 EPS of $0.81-$0.91. Select Medical Holdings sees FY2017 revenue of $4.4-4.5 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.